---All---
  • ---All---
  • Accession
  • Catalog #

AIF1 Antibody (N-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP10449a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AIF1 Antibody (N-term) Blocking Peptide - Product info

Primary AccessionP55008
Other AccessionNP_001614.3
Clone Names80102115
Calculated MW16703 Da

AIF1 Antibody (N-term) Blocking Peptide - Additional info

Gene ID 199
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

AIF1 Antibody (N-term) Blocking Peptide - Protein Information

Name AIF1
Synonyms G1, IBA1
Function
Actin-binding protein that enhances membrane ruffling and RAC activation. Enhances the actin-bundling activity of LCP1 Binds calcium. Plays a role in RAC signaling and in phagocytosis May play a role in macrophage activation and function. Promotes the proliferation of vascular smooth muscle cells and of T- lymphocytes. Enhances lymphocyte migration. Plays a role in vascular inflammation
Cellular Location
Cytoplasm, cytoskeleton. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side Note=Associated with the actin cytoskeleton at membrane ruffles and at sites of phagocytosis
Tissue Location
Detected in T-lymphocytes and peripheral blood mononuclear cells

AIF1 Antibody (N-term) Blocking Peptide - Related products

AP10449a: AIF1 Antibody (N-term)

AP11202b: AIF1 Antibody (C-term)

RI10186: AIF1 predesign siRNA

BP10449a: AIF1 Antibody (N-term) Blocking Peptide

AT1077a: AIF1 Antibody (monoclonal) (M01)

AF1039a: AIF1 / IBA1 (isoform 1 and 3) Antibody

AF1039b: AIF1 / IBA1 (isoform 3) Antibody

AF1039c: AIF1 / IBA1 (isoforms 1 + 3) Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

AIF1 is thought to be involved in negative regulation ofgrowth of vascular smooth muscle cells, which contributes to theanti-inflammatory response to vessel wall trauma.

REFERENCES

Clancy, R.M., et al. Arthritis Rheum. 62(11):3415-3424(2010)Ucisik-Akkaya, E., et al. Mol. Hum. Reprod. 16(10):770-777(2010)Davila, S., et al. Genes Immun. 11(3):232-238(2010)Jia, J., et al. Pediatr. Res. 67(1):29-34(2010)Barcellos, L.F., et al. PLoS Genet. 5 (10), E1000696 (2009) :